SEC Form 4 · accession 0001437749-26-026608
TG THERAPEUTICS, INC. · TGTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laurence N Charney
Director
Period of report
Aug 6, 2026
Accepted (ET)
Aug 7, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001001316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 6, 2026 | G | 5,100 | $0.00 | D | 174,590 | D | |
| Common StockF1,F2 | Aug 7, 2026 | G | 500 | $0.00 | D | 174,090 | D | |
| Common StockF1,F2 | Aug 7, 2026 | G | 450 | $0.00 | D | 173,640 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F11. Represents a bona fide gift by the Reporting Person to a 501(c)(3) institution. The Reporting Person does not retain any beneficial ownership or pecuniary interest over the shares of the Company's Common Stock after effecting the transaction.
- F22. Includes shares of restricted Common Stock, which vest over various time periods.